Bright Minds Biosciences Inc
CNSX:DRUG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
CA |
|
Capitan Investment Ltd
XTSX:CAI
|
CA |
Shareholder Yield
Current shareholder yield for DRUG is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
DRUG Price
Bright Minds Biosciences Inc
| Average Annual Return | 698.22% |
| Standard Deviation of Annual Returns | 1 388.02% |
| Max Drawdown | -95% |
| Market Capitalization | 1.2B CAD |
| Shares Outstanding | 9 790 000 |
| Percentage of Shares Shorted | 0.12% |
DRUG Return Decomposition
Main factors of price return
Stock Splits
DRUG's latest stock split occurred on Jul 14, 2023
The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.
Before the split, DRUG traded at 0.8 per share. Afterward, the share price was about 4.48.
The adjusted shares began trading on Jul 14, 2023. This was the only stock split in DRUG's history.
